IMPRIMIS PHARMACEUTICALS, INC. SC 13G

Company

HARROW, INC.

Filed

March 21, 2016

Accession Number

0000905718-16-001269

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →